{"id":"metronidazole-and-azithromycin","safety":{"commonSideEffects":[{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Diarrhea"},{"rate":null,"effect":"Abdominal pain"},{"rate":null,"effect":"Metallic taste (metronidazole)"},{"rate":null,"effect":"QT prolongation (azithromycin)"},{"rate":null,"effect":"Photosensitivity"}]},"_chembl":{"chemblId":"CHEMBL137","moleculeType":"Small molecule","molecularWeight":"171.16"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Metronidazole is a nitroimidazole that generates reactive oxygen species in anaerobic bacteria, damaging their DNA. Azithromycin is a macrolide antibiotic that binds to the bacterial 50S ribosomal subunit, inhibiting protein synthesis. Together, they provide broad-spectrum coverage against both anaerobic and aerobic bacteria, commonly used in polymicrobial infections.","oneSentence":"This combination uses metronidazole to disrupt bacterial DNA and azithromycin to inhibit bacterial protein synthesis, together targeting anaerobic and aerobic pathogens.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:54:58.540Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Polymicrobial infections including anaerobic and aerobic bacteria"},{"name":"Intra-abdominal infections"},{"name":"Pelvic inflammatory disease"},{"name":"Aspiration pneumonia"}]},"trialDetails":[{"nctId":"NCT05894954","phase":"PHASE3","title":"Precision Medicine Approach for Early Dementia & Mild Cognitive Impairment","status":"COMPLETED","sponsor":"Alzheimer's Prevention and Reversal Project, Inc.","startDate":"2023-07-31","conditions":"Mild Cognitive Impairment, Dementia, Mild","enrollment":73},{"nctId":"NCT06396078","phase":"PHASE4","title":"Improvement of PPROM Management With Prophylactic Antimicrobial Therapy (iPROMPT)","status":"RECRUITING","sponsor":"Ohio State University","startDate":"2024-07-18","conditions":"Preterm Premature Rupture of Membrane, Pregnancy, High Risk, Preterm Birth","enrollment":56},{"nctId":"NCT04186247","phase":"PHASE2","title":"Personalized AZithromycin/metronidAZole Therapy in Pediatric Crohn's Disease (CD)","status":"TERMINATED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2021-08-13","conditions":"Crohn Disease, Pediatric Crohns Disease","enrollment":13},{"nctId":"NCT05812820","phase":"NA","title":"Effects of Probiotic in Treatment of Persistent Diarrhea in Children","status":"COMPLETED","sponsor":"National Children's Hospital, Vietnam","startDate":"2022-07-01","conditions":"Diarrhea","enrollment":165},{"nctId":"NCT04669717","phase":"PHASE4","title":"Antibiotics as Adjuncts to Periodontal Therapy:Pharmacokinetic Considerations and Dosing Strategies","status":"RECRUITING","sponsor":"University of Geneva, Switzerland","startDate":"2021-09-01","conditions":"Periodontal Diseases, Antibiotics, Pharmacokinetics","enrollment":45},{"nctId":"NCT06349122","phase":"PHASE4","title":"Screen-and-treat Strategy for Vaginal Flora Abnormalities in Pregnant Women at High Risk of Preterm Birth","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique Hopitaux De Marseille","startDate":"2024-08","conditions":"Bacterial Vaginosis, Vaginal Dysbiosis, Premature Delivery","enrollment":1292},{"nctId":"NCT06093360","phase":"","title":"Flapless Surgical Treatment of Peri-implantitis","status":"COMPLETED","sponsor":"Universidad Complutense de Madrid","startDate":"2018-01-01","conditions":"Peri-Implantitis","enrollment":117},{"nctId":"NCT05293977","phase":"NA","title":"Short-Term Use of Antibiotics and Adherence Level","status":"COMPLETED","sponsor":"Jordan University of Science and Technology","startDate":"2020-08-03","conditions":"Acute Infection","enrollment":589},{"nctId":"NCT02099240","phase":"EARLY_PHASE1","title":"Patients Response to Early Switch To Oral:Osteomyelitis Study","status":"TERMINATED","sponsor":"Julio Ramirez","startDate":"2014-03-06","conditions":"Osteomyelitis","enrollment":11},{"nctId":"NCT03079388","phase":"NA","title":"Nutritional and Anti-infective Interventions for Malnutrition in Pregnancy (Beleuman Welbodi)","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2017-02-27","conditions":"Pregnancy, Malnutrition in Pregnancy, Nutrition Disorders","enrollment":1489},{"nctId":"NCT03862456","phase":"NA","title":"Metronidazole vs Azithromycin in Periodontal Surgery for Patients Positive to Porphyromonas Gingivalis","status":"UNKNOWN","sponsor":"Universidad Complutense de Madrid","startDate":"2013-01","conditions":"Periodontitis, Surgery","enrollment":50},{"nctId":"NCT03571230","phase":"PHASE4","title":"Antimicrobial Susceptibility Testing Guided Therapy Versus Empirical Therapy for the First-line Helicobacter Pylori Eradication.","status":"UNKNOWN","sponsor":"Shandong University","startDate":"2018-07-01","conditions":"Helicobacter Pylori Infection, Antimicrobial Susceptibility Testing","enrollment":400},{"nctId":"NCT01596894","phase":"PHASE4","title":"Azithromycin Based Therapy for Induction of Remission in Active Pediatric Crohn's Disease","status":"COMPLETED","sponsor":"Prof. Arie Levine","startDate":"2012-10","conditions":"Crohn's Disease","enrollment":73},{"nctId":"NCT00324818","phase":"PHASE4","title":"Treatment of Bacterial Vaginosis","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2002-07","conditions":"Bacterial Vaginosis","enrollment":600},{"nctId":"NCT00713999","phase":"NA","title":"Urogenital Schistosomiasis and Sexually Transmitted Infections in Madagascar","status":"COMPLETED","sponsor":"University of Aarhus","startDate":"2001-08","conditions":"Sexually Transmitted Infections, Schistosoma Haematobium","enrollment":680}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"metronidazole and azithromycin","genericName":"metronidazole and azithromycin","companyName":"University of Alabama at Birmingham","companyId":"university-of-alabama-at-birmingham","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This combination uses metronidazole to disrupt bacterial DNA and azithromycin to inhibit bacterial protein synthesis, together targeting anaerobic and aerobic pathogens. Used for Polymicrobial infections including anaerobic and aerobic bacteria, Intra-abdominal infections, Pelvic inflammatory disease.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}